Drug Information

Drug General Information
Drug ID
D0ZW8E
Former ID
DNC013241
Drug Name
L-isoleucyl-L-prolinamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527857]
Structure
Download
2D MOL

3D MOL
Formula
C11H21N3O2
Canonical SMILES
CCC(C)C(C(=O)N1CCCC1C(=O)N)N
InChI
1S/C11H21N3O2/c1-3-7(2)9(12)11(16)14-6-4-5-8(14)10(13)15/h7-9H,3-6,12H2,1-2H3,(H2,13,15)/t7?,8-,9-/m0/s1
InChIKey
HCKIVERTZIJTOT-NPPUSCPJSA-N
PubChem Compound ID
11673051
Target and Pathway
Target(s) Tripeptidyl-peptidase II Target Info Inhibitor [527857]
Reactome Antigen processing: Ubiquitination & Proteasome degradation
References
Ref 527857J Med Chem. 2005 Nov 17;48(23):7333-42.Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach to designing exopeptidase inhibitors.
Ref 527857J Med Chem. 2005 Nov 17;48(23):7333-42.Inhibitors of tripeptidyl peptidase II. 3. Derivation of butabindide by successive structure optimizations leading to a potential general approach to designing exopeptidase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.